POZEN Inc. announced that John R. Plachetka, Pharm.D., its founder, Chairman, Chief Executive Officer and President is retiring, effective immediately. Dr. Plachetka has also resigned from the Board of Directors of POZEN and has withdrawn as a nominee for election as a director at the 2015 Annual Meeting of Stockholders. Arthur Kirsch, who has served as an independent director since 2004, has been appointed to serve as Chairman of POZEN's Board of Directors.

The Board of Directors has appointed Adrian Adams to replace Dr. Plachetka as POZEN's Chief Executive Officer and has also appointed Mr. Adams to serve on the Board of Directors, effective immediately. Mr. Adams most recently served as Chief Executive Officer and President of Auxilium Pharmaceuticals Inc. POZEN also announced that the Board of Directors has appointed Andrew Koven as President and Chief Business Officer, reporting to Mr. Adams. Mr. Koven most recently served as Chief Administrative Officer and General Counsel of Auxilium Pharmaceuticals Inc.